Ulf P Neumann Selected Research

Muromonab-CD3 (Muromonab CD3)

8/2005	Changing impact of cytomegalovirus in liver transplantation -- a single centre experience of more than 1000 transplantations without ganciclovir prophylaxis.
12/2002	CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
5/2002	Simultaneous splenectomy increases risk for opportunistic pneumonia in patients after liver transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ulf P Neumann Research Topics

Disease

30	Neoplasms (Cancer) 03/2022 - 05/2007
12	Neoplasm Metastasis (Metastasis) 06/2022 - 07/2009
12	Fibrosis (Cirrhosis) 01/2019 - 04/2002
10	Cholangiocarcinoma 03/2022 - 01/2013
10	Inflammation (Inflammations) 04/2020 - 07/2007
9	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2011
9	Hepatitis C 10/2011 - 01/2004
7	Infections 03/2012 - 04/2002
6	Adenocarcinoma 03/2021 - 06/2017
5	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 05/2007
5	Liver Diseases (Liver Disease) 01/2021 - 03/2011
4	Ischemia 11/2021 - 07/2008
4	Reperfusion Injury 11/2021 - 07/2009
4	Klatskin Tumor 10/2021 - 11/2009
4	Obesity 01/2021 - 11/2015
4	Sclerosing Cholangitis 01/2019 - 01/2003
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 09/2010
3	Weight Loss (Weight Reduction) 07/2020 - 11/2015
3	Anastomotic Leak 01/2019 - 08/2012
3	Reinfection 03/2012 - 04/2002
3	Disease Progression 06/2010 - 12/2002
3	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 06/2010 - 03/2006
2	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 11/2021
2	Liver Failure 01/2022 - 01/2016
2	Hyperthermia 11/2021 - 01/2017
2	Cholangitis 01/2021 - 02/2008
2	Pneumonia (Pneumonitis) 01/2020 - 05/2002
2	Foreign-Body Reaction 01/2019 - 01/2012
2	Foreign Bodies (Foreign Body) 01/2019 - 01/2017
2	Non-alcoholic Fatty Liver Disease 01/2019 - 11/2015
2	Necrosis 01/2017 - 05/2013
2	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2016 - 09/2010
2	Acute Liver Failure (Fulminant Hepatic Failure) 10/2014 - 08/2005
2	Cicatrix (Scar) 09/2013 - 02/2012
2	Wound Infection (Wound Infections) 08/2012 - 04/2011
2	Hypertension (High Blood Pressure) 10/2011 - 08/2005
2	Renal Insufficiency (Renal Failure) 10/2011 - 04/2011
2	Hypoxia (Hypoxemia) 01/2010 - 07/2008
2	Hepatitis 07/2007 - 12/2002
1	Uveal melanoma 06/2022
1	Hypertrophy 06/2022
1	Hepatic Insufficiency 06/2022
1	Appendicitis 03/2022
1	Hyperbilirubinemia 08/2021
1	Sarcopenia 03/2021

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 10/2021 - 09/2010
4	Urokinase Plasminogen Activator ReceptorsIBA 04/2020 - 10/2014
4	SteroidsIBA 03/2006 - 12/2002
3	6-propylchromone-2-carboxylic acid (PCCA)IBA 10/2021 - 01/2020
3	CollagenIBA 01/2020 - 01/2012
3	Biocompatible Materials (Biomaterials)IBA 01/2019 - 05/2011
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2019 - 01/2010
3	ChemokinesIBA 01/2019 - 02/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 03/2006
3	Erythropoietin FDA Link 01/2010 - 07/2008
3	Muromonab-CD3 (Muromonab CD3)FDA Link 08/2005 - 05/2002
2	Tumor Biomarkers (Tumor Markers)IBA 10/2021 - 04/2020
2	Bile Acids and Salts (Bile Acids)IBA 08/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2016
2	Polypropylenes (Polypropylene)IBA 01/2019 - 01/2017
2	CytokinesIBA 01/2019 - 01/2010
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 04/2002
2	nasIBA 01/2019 - 11/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 01/2010
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2017
2	OsteopontinIBA 10/2018 - 10/2017
2	CreatinineIBA 06/2018 - 03/2006
2	Indicators and Reagents (Reagents)IBA 01/2017 - 02/2012
2	Protein Kinases (Protein Kinase)IBA 01/2017 - 01/2016
2	Messenger RNA (mRNA)IBA 12/2016 - 01/2010
2	Phosphotransferases (Kinase)IBA 10/2016 - 01/2016
2	Antiviral Agents (Antivirals)IBA 01/2013 - 02/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010 - 07/2008
2	CholesterolIBA 03/2006 - 08/2005
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2004 - 01/2003
2	HLA-DR Antigens (HLA-DR)IBA 01/2003 - 12/2002
1	Untranslated RNA (Noncoding RNA)IBA 01/2022
1	Competitive Endogenous RNAIBA 01/2022
1	Aprotinin (Trasylol)FDA Link 11/2021
1	MTOR InhibitorsIBA 11/2021
1	Sirolimus (Rapamycin)FDA Link 11/2021
1	Taurocholic Acid (Sodium Taurocholate)IBA 08/2021
1	Peptides (Polypeptides)IBA 08/2021
1	Immune Checkpoint InhibitorsIBA 03/2021

Therapy/Procedure

30	Liver Transplantation 11/2021 - 04/2002
17	Therapeutics 11/2021 - 03/2006
10	Transplantation 01/2022 - 08/2005
8	Hepatectomy 06/2022 - 11/2009
5	Bariatric Surgery 01/2021 - 06/2015
4	Sutures (Suture) 08/2019 - 01/2011
3	Drug Therapy (Chemotherapy) 01/2021 - 07/2009
3	Length of Stay 06/2014 - 04/2011
3	Splenectomy 10/2012 - 05/2002
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 08/2005
2	Aftercare (After-Treatment) 01/2019 - 02/2007
2	Contraindications 08/2015 - 01/2013
2	Conservative Treatment 08/2015 - 02/2008
1	Appendectomy 03/2022
1	Photothermal Therapy 11/2021
1	Esophagectomy 03/2021